Treating latent tuberculosis : Efficacy of rifapentine plus isoniazid combination therapy vs. isoniazid monotherapy
Latent tuberculosis infection (LTBI) is a global health issue that affects approximately one quarter of the world’s population. It refers to a state of persistent immune response to Mycobacterium tuberculosis without clinical evidence of active tuberculosis (TB). Latent tuberculosis infected individ...
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | English |
| Published: |
Linnéuniversitetet, Institutionen för kemi och biomedicin (KOB)
2021
|
| Subjects: | |
| Online Access: | http://urn.kb.se/resolve?urn=urn:nbn:se:lnu:diva-102102 |